Back
Madrigal Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
MDGL
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
48
MDGL
Madrigal Pharmaceuticals
Last Price:
233.88
Seasonality Move:
20.78%
7 Day Trial
ALL ACCESS PASS
$
7
10 minutes on Tuesday - $1,270 by Friday?
Click here to discover how this "odd" trade could double your money each week.Madrigal Pharmaceuticals Price Quote
$233.88
+0.44 (+-3.46%)
(Updated: September 21, 2024 at 6:32 AM ET)
Madrigal Pharmaceuticals Key Stats
Sell
48
Madrigal Pharmaceuticals (MDGL)
is a Sell
Day range:
$233.00 - $244.23
52-week range:
$119.76 - $299.98
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
5.91%
Volume:
290.6K
Avg. volume:
214.9K
1-year change:
44.62%
Market cap:
$5.1B
Revenue:
$0
EPS:
$-25.54
How Much Does Madrigal Pharmaceuticals Make?
Data Unavailable
Is Madrigal Pharmaceuticals Growing As A Company?
Data Unavailable
Madrigal Pharmaceuticals Stock Price Performance
-
Did Madrigal Pharmaceuticals Stock Go Up Last Month?
Madrigal Pharmaceuticals share price went down by -9.93% last month -
Did MDGL's Share Price Rise Over The Last Year?
MDGL share price rose by 44.62% over the past 1 year
What Is Madrigal Pharmaceuticals 52-Week High & Low?
-
What Is Madrigal Pharmaceuticals’s 52-Week High Share Price?
Madrigal Pharmaceuticals has traded as high as $299.98 over the past 52 weeks -
What Is Madrigal Pharmaceuticals’s 52-Week Low Share Price?
Madrigal Pharmaceuticals has traded as low as $119.76 over the past 52 weeks
Madrigal Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Madrigal Pharmaceuticals?
-
How Much Debt Does Madrigal Pharmaceuticals Have?
Total long term debt quarterly is $116.6M -
How Much Cash Does Madrigal Pharmaceuticals Have?
Cash and short term investments quarterly total is $1.1B -
What Is Madrigal Pharmaceuticals’s Book Value Per Share?
Book value per share is 39.50
Is Madrigal Pharmaceuticals Cash Flow Positive?
-
What Is MDGL Cash Flow From Operations?
Cash flow from operations (TTM) is -$449M -
What Is Madrigal Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $1.2B -
What Is Madrigal Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$336M
Madrigal Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
MDGL return on invested capital is -91.11% -
What Is Madrigal Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -75.89% -
What Is MDGL Return On Equity?
ROE is a measure of profitability and is -113.99%
Madrigal Pharmaceuticals Earnings Date & Stock Price
-
What Is Madrigal Pharmaceuticals's Stock Price Today?
A single share of MDGL can be purchased today for 233.44 -
What Is Madrigal Pharmaceuticals’s Stock Symbol?
Madrigal Pharmaceuticals trades on the nasdaq under the ticker symbol: MDGL -
When Is Madrigal Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Madrigal Pharmaceuticals is scheduled on November 6, 2024 -
When Is MDGL's next ex-dividend date?
Madrigal Pharmaceuticals's next ex-dividend date is September 21, 2024 -
How To Buy Madrigal Pharmaceuticals Stock?
You can buy Madrigal Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Madrigal Pharmaceuticals Competitors
-
Who Are Madrigal Pharmaceuticals's Competitors?
Below is a list of companies who compete with Madrigal Pharmaceuticals or are related in some way:
Madrigal Pharmaceuticals Dividend Yield
-
What Is MDGL Dividend Yield?
Madrigal Pharmaceuticals’s dividend yield currently is 0% -
What Is Madrigal Pharmaceuticals’s Payout Ratio?
Madrigal Pharmaceuticals’s payout ratio is 0% -
When Did Madrigal Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is September 21, 2024 -
What Is Madrigal Pharmaceuticals’s Dividend Per Share?
Madrigal Pharmaceuticals pays a dividend of $0.00 per share
Madrigal Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 7.33% |
Revenue: | 0% | 233.98% |
Analyst Recommendations
Buy Recommendations: | 7 |
---|---|
Hold Recommendations: | 3 |
Sell Recommendations: | 0 |
Price Target: | 360.57 |
Upside from Last Price: | 54.46% |